Pfizer is studying an investigational pneumococcal vaccine and needs healthy Black adults ages 18-49 to join the clinical trial. Learn what participation involves and why diverse representation matters in vaccine research.
The postWhy Healthy Black Adults Are Essential to the Future of Pneumococcal Vaccine Researchappeared first onBlack Health Matters.



